Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Predictive Oncology Inc. (POAI) had Return on Tangible Equity of -174.38% for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$1.78M
Net Income	$-13.98M
Cost of Goods Sold	$0.63M
Gross Profit	$1.15M
Operating Expenses	$15.86M
Operating Income	$-14.08M
Non-Operating Income/Expense	$0.10M
Pre-Tax Income	$-13.98M
Normalized Pre-Tax Income	$-14.00M
Income after Taxes	$-13.98M
Income from Continuous Operations	$-13.98M
Consolidated Net Income/Loss	$-13.98M
Normalized Income after Taxes	$-14.00M
EBIT	$-14.08M
EBITDA	$-13.34M
Weighted-Average Shares Outstanding (Basic)	4.01M
Weighted-Average Shares Outstanding (Diluted)	4.01M
Earnings per Share (EPS) (Basic)	$-3.48
Earnings per Share (EPS) (Diluted)	$-3.48
Balance Sheet Financials
Current Assets	$10.08M
Property, Plant, and Equipment	$1.23M
Long-Term Assets	$4.34M
Total Assets	$14.42M
Current Liabilities	$3.95M
Long-Term Debt	--
Long-Term Liabilities	$2.19M
Total Liabilities	$6.15M
Common Equity	$8.27M
Tangible Shareholders Equity	$8.02M
Shareholders Equity	$8.27M
Common Shares Outstanding	4.06M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-13.19M
Cash Flow from Investing Activities	$-0.30M
Cash Flow from Financial Activities	$0.15M
Beginning Cash	$22.07M
End Cash	$8.73M
Increase/Decrease in Cash	$-13.34M
Stock-Based Compensation	$0.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.55
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.02
Gross Margin	64.34%
Operating Margin	-791.21%
EBIT Margin	-791.21%
EBITDA Margin	-749.68%
Pre-Tax Profit Margin	-785.58%
Profit Margin	-785.58%
Free Cash Flow	$-13.47M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	1.28
Receiveable Turnover	5.33
Days Sales in Receivables	68.42
Return on Equity	-169.07%
Return on Tangible Equity	-174.38%
Return on Assets	-96.99%
Return on Investments	-169.06%
Book Value Per Share	$2.04
Free Cash Flow per Share	$-3.35
Operating Cash Flow per Share	$-3.29

Data from Zacks Investment Research, Inc.